The Alphabet Health Agencies Ignoring of the Repurposed Drug Fluvoxamine

I published an Op-Ed in the Federalist weeks ago. There is no better example of the absurd tactics the Pharma captured agencies employ to suppress use of repurposed drugs. New Tactic: "The Ignore"

Feb 02, 2022

∙ Paid

**Authors note: Big thanks to Steve Kirsch and his Covid Early Treatment Foundation’s efforts to support research into and knowledge of the highly effective COVID-19 medicine fluvoxamine. The FLCCC added the medicine 8 months ago. The agencies and societies contnue to ignore the now massive evidence base behind it.

My Op-Ed written at the beginning of the Omicron wave:

Continue reading this post for free, courtesy of Pierre Kory, MD, MPA.

Or purchase a paid subscription.